Clinical Trial Update: Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation [Phase 4]

View source ↗

Summary

This is a post-market Phase 4 clinical study evaluating the CardioFocus Endoscopic Ablation System with Adaptive Contact for treating symptomatic atrial fibrill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC)

Snippet

Sponsor: CardioFocus | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2016-07-27